A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.

Abstract:

OBJECTIVE:To determine the acceptability of taking mifepristone at home for early medical abortion in the United States. STUDY DESIGN:This prospective, non-randomized, open-label study at six Planned Parenthood centers gave women with pregnancies up to 63 days' gestation seeking medical abortion the choice of taking mifepristone in the center or at home. Participants were interviewed at a follow-up visit 1-2 weeks after mifepristone administration to assess their experience with the option they selected. RESULTS:Four-hundred women were enrolled between April 2013 and June 2014 of which 32% (n=128) chose to take mifepristone at home. Abortion success rates did not differ between home and center users (96% and 97%). Among home users, 82% reported taking the mifepristone at the time they planned with their provider and no participant took it after 63 days' gestation. The most common reason cited for selecting home use was scheduling flexibility and significantly more home users took misoprostol on the weekend (50% vs. 36%, p=.02). Home users were more likely than center users to report missing no days of work due to the abortion (47% vs. 28%, p=.08). Ninety-nine percent of home users reported that they would take mifepristone at home again and 96% would recommend home use to a friend. Offering this option did not increase the service delivery burden on study providers, who would recommend home use in the future for most participants. CONCLUSIONS:Home use of mifepristone is a highly acceptable practice for which there is current demand, and it should be offered as part of routine medical abortion services. IMPLICATIONS:Offering the option of home use of mifepristone to medical abortion patients can provide women and clinics with more flexibility while maintaining a safe, effective and acceptable service. These results provide support for telemedicine or pharmacy distribution.

journal_name

Contraception

journal_title

Contraception

authors

Chong E,Frye LJ,Castle J,Dean G,Kuehl L,Winikoff B

doi

10.1016/j.contraception.2015.06.026

subject

Has Abstract

pub_date

2015-09-01 00:00:00

pages

215-9

issue

3

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(15)00277-2

journal_volume

92

pub_type

临床试验,杂志文章,多中心研究
  • Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.

    abstract::The objective of this double-blind, placebo-controlled study was to evaluate the effect of mefenamic acid and placebo on controlling irregular uterine bleeding in depot-medroxyprogesterone acetate (DMPA) users. A total of 48 DMPA users attending the Family Planning Clinic, Chulalongkorn Hospital were studied, all had ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2004.04.003

    authors: Tantiwattanakul P,Taneepanichskul S

    更新日期:2004-10-01 00:00:00

  • Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.

    abstract:BACKGROUND:This study analyzes levels of progesterone, estradiol, norethindrone (NET) and ethinyl estradiol (EE) in serum and levels of NET in cervical mucus on the last day of the hormone-free interval (HFI) in users of 24/4 [norethindrone acetate (NETA)/EE-24] vs. 21/7 (NETA/EE-21) regimens. STUDY DESIGN:This was a ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2012.12.006

    authors: Fels H,Steward R,Melamed A,Granat A,Stanczyk FZ,Mishell DR Jr

    更新日期:2013-06-01 00:00:00

  • The postcoital IUD as an effective continuing contraceptive method.

    abstract::A two-year controlled clinical study of the effectiveness of postcoital IUD as a continuing contraceptive method in 98 women requesting a postcoital contraception is presented. The control group was selected from women requesting an IUD as contraceptive choice. The rates of accidental pregnancy, expulsion and removal ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(86)80011-7

    authors: Gottardi G,Spreafico A,de Orchi L

    更新日期:1986-12-01 00:00:00

  • Emergency contraception in South Africa: knowledge, attitudes, and use among public sector primary healthcare clients.

    abstract::To determine knowledge of, attitudes toward, and use of emergency contraception (EC), interviews were held with 1068 clients of 89 public sector primary healthcare facilities in two urban and two rural areas of South Africa. Only 22.8% of the clients had heard of EC. Awareness was significantly lower in the most rural...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/s0010-7824(01)00272-4

    authors: Smit J,McFadyen L,Beksinska M,de Pinho H,Morroni C,Mqhayi M,Parekh A,Zuma K

    更新日期:2001-12-01 00:00:00

  • Lactobacillus species isolated from the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance.

    abstract:BACKGROUND:Lactic acid production is considered to be the major protection mechanism of lactobacilli against vaginal infections due to genital pathogens. Some species of Lactobacillus are also hydrogen peroxide (H(2)O(2)) producers. Nonoxynol-9 (N-9) is a nonionic detergent and is the active component of many spermicid...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.06.066

    authors: Pascual LM,Daniele MB,Pájaro C,Barberis L

    更新日期:2006-01-01 00:00:00

  • Emergency contraception in Jordan: Assessing retail pharmacists' awareness, opinions, and perceptions of need.

    abstract:OBJECTIVES:Jordan has a robust contraceptive method mix in both the public and private sectors and oral contraceptive pills and the copper-T intrauterine device are widely available. However, Jordan remains one of only a few countries in the world without a registered dedicated product for emergency contraception (EC)....

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.10.002

    authors: El-Mowafi IM,Foster AM

    更新日期:2020-04-01 00:00:00

  • Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.

    abstract::A prospective randomized trial was conducted in 140 women to compare the efficacy of vaginal gemeprost with vaginal misoprostol for termination of second trimester pregnancy. Women requesting termination of second trimester pregnancy were randomized into two groups. Group A women were given 1 mg vaginal gemeprost ever...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(98)00099-7

    authors: Wong KS,Ngai CS,Wong AY,Tang LC,Ho PC

    更新日期:1998-10-01 00:00:00

  • Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.

    abstract:OBJECTIVE:The study was conducted to evaluate the effect of Carraguard vaginal gel containing 0.75 mg of levonorgestrel (CARRA/LNG gel) administered in a single dose at different stages of follicle development over subsequent follicle rupture and hormonal levels. METHOD:Randomized, blinded, cross-over study comparing ...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2007.04.005

    authors: Brache V,Croxatto H,Sitruk-Ware R,Maguire R,Montero JC,Kumar N,Salvatierra AM,Tejada AS,Cochón L,Forcelledo ML,Lahteenmaki P,Alvarez F,Faundes A

    更新日期:2007-08-01 00:00:00

  • Mobile phone ownership, text messages, and contraceptive use: Is there a digital revolution in family planning?

    abstract:OBJECTIVES:This study aims to clarify the associations between mobile phone ownership use on family planning outcomes. Secondary analysis of DHS data finds that in certain contexts, mobile phone ownership may be related to increased FP uptake. STUDY DESIGN:Using recent data for women 15-49 from the Demographic and Hea...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.10.004

    authors: Jadhav A,Weis J

    更新日期:2020-02-01 00:00:00

  • Cyproterone acetate affects protamine gene expression in the testis of adult male rat.

    abstract::The temporal effects of oral administration of cyproterone acetate (CPA), a progestational androgen receptor blocker, were studied on the fertility of adult male rat sires, at a dose of 20 mg kg-1 day-1 after 15 days of gavage. The treatment reduced the fertility and weights of accessory sex glands, without altering t...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.11.003

    authors: Aleem M,Padwal V,Choudhari J,Balasinor N,Parte P,Gill-Sharma M

    更新日期:2005-05-01 00:00:00

  • Knowledge of the risks and benefits associated with oral contraception in a university-aged sample of users and non-users.

    abstract::As research has shown that knowledge concerning the health risks and benefits of oral contraceptive (OC) use is a contributor to OC compliance, the following study examined an educated sample of young women to determine the level of knowledge concerning the risks and benefits of OC use. A 28-item questionnaire was dev...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(01)00194-9

    authors: Bryden PJ,Fletcher P

    更新日期:2001-04-01 00:00:00

  • Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.

    abstract:OBJECTIVES:To measure the 24-month impact on continuation, unintended pregnancy and satisfaction of trying long-acting reversible contraception (LARC) in a population seeking short-acting reversible contraception (SARC). STUDY DESIGN:We enrolled 916 women aged 18-29 who were seeking pills or injectables in a partially...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2018.02.001

    authors: Hubacher D,Spector H,Monteith C,Chen PL

    更新日期:2018-06-01 00:00:00

  • Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.

    abstract::Changes in body weight and the incidence of estrogen-related side effects with low-dose oral contraceptives (OCs) containing 20 microg ethinyl estradiol (EE) have not been demonstrated in placebo-controlled trials. Two placebo-controlled, randomized trials demonstrated the efficacy of a low-dose OC for the treatment o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(01)00208-6

    authors: Coney P,Washenik K,Langley RG,DiGiovanna JJ,Harrison DD

    更新日期:2001-06-01 00:00:00

  • Emerging evidence on oral contraceptives and arterial disease.

    abstract::A number of case-control studies published in recent years have shown an apparent increase in the risk of venous thromboembolism (VTE) associated with the use of third-generation oral contraceptives (OCs) compared with second-generation OCs. However, it is thought that these studies were subject to a number of biases ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/s0010-7824(00)00146-3

    authors: Heinemann LA

    更新日期:2000-08-01 00:00:00

  • Economic analysis of contraceptives for women.

    abstract:OBJECTIVE:To examine from the health care services payer perspective the economic consequences of contraceptives available to women in the United States. METHODS:A Markov model was constructed to compare effectiveness and costs among nine contraceptive methods (including 3-month injectable, oral contraceptives, intrau...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(03)00078-7

    authors: Chiou CF,Trussell J,Reyes E,Knight K,Wallace J,Udani J,Oda K,Borenstein J

    更新日期:2003-07-01 00:00:00

  • A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.

    abstract::A morphometric study was undertaken to quantitate vessel numbers in uterine biopsies from a control group of patients, patients with dysfunctional uterine bleeding and patients taking low dose norethisterone or levonorgestrel. Vessels were counted at the endometrial/myometrial junction and in the functional endometriu...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(86)80016-6

    authors: Hourihan HM,Sheppard BL,Bonnar J

    更新日期:1986-12-01 00:00:00

  • Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.

    abstract:BACKGROUND:This study evaluated the ethinyl estradiol (EE) and levonorgestrel (LNG) pharmacokinetic profiles of AG200-15, a transdermal contraceptive delivery system, compared with a combination oral contraceptive (COC) containing EE 35 mcg and norgestimate 250 mcg. STUDY DESIGN:A Phase 1, open-label, single-center st...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2011.10.006

    authors: Archer DF,Stanczyk FZ,Rubin A,Foegh M

    更新日期:2012-06-01 00:00:00

  • Observations of scanning electron microscopy detected abnormalities of non-lubricated latex condoms.

    abstract::To describe surface abnormalities found by scanning electron microscopy of non-lubricated latex condoms, thirty samples of 15 condoms were photographed at low (26-94x), medium (240-940x) and high (> 1000x) magnification. Each sample was initially scanned at low magnification to determine the presence and location of s...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(95)00259-6

    authors: Rosenzweig BA,Even A,Budnick LE

    更新日期:1996-01-01 00:00:00

  • Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion.

    abstract::This study was undertaken to assess the effects of different tubal occlusion procedures on ovarian function. Three groups of subjects randomized to tubal occlusion by laparoscopy and Yoon ring (24 subjects), minilaparotomy and Yoon ring (19 subjects) and minilaparotomy and Pomeroy (22 subjects), and one separate contr...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(89)90003-6

    authors: Rivera R,Gaitan JR,Ruiz R,Hurley DP,Arenas M,Flores C,Hernandez AB

    更新日期:1989-08-01 00:00:00

  • Transdermal delivery of steroids.

    abstract::The advantages of delivering drugs through the skin for systemic therapy have been widely recognized and represent a growing sector in drug development. Transdermal delivery of steroids is also a rapidly expanding field and in various clinical situations where hormonal replacement therapy is needed this route of admin...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(89)90012-7

    authors: Sitruk-Ware R

    更新日期:1989-01-01 00:00:00

  • Estimating systemic exposure to levonorgestrel from an oral contraceptive.

    abstract:OBJECTIVE:The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies fo...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2016.12.007

    authors: Basaraba CN,Westhoff CL,Pike MC,Nandakumar R,Cremers S

    更新日期:2017-04-01 00:00:00

  • Impact of tubal ligation on ovarian reserve as measured by anti-Müllerian hormone levels: a prospective cohort study.

    abstract:BACKGROUND:Tubal ligation (TL) is considered a very efficient contraceptive method. However, some patients complain of a variety of postoperative symptoms. The objective of this study was to investigate whether ovarian reserve may change after tubal ligation. STUDY DESIGN:This was a prospective cohort study of 80 fert...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.09.021

    authors: Silva AL,Ré Cd,Dietrich C,Fuhrmeister IP,Pimentel A,Corleta HV

    更新日期:2013-12-01 00:00:00

  • Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens.

    abstract:OBJECTIVE:The objective was to investigate changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and progesterone (P) during the hormone-free interval (HFI) of 6 combined oral contraceptives (COCs). DESIGN:Blood samples were obtained from 62 women. RESULTS:When COCs were grouped by e...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2014.01.021

    authors: Cho M,Atrio J,Lim AH,Azen C,Stanczyk FZ

    更新日期:2014-07-01 00:00:00

  • Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure.

    abstract::The present study was designed to evaluate the effectiveness of a once-weekly regimen of GnRH antagonist followed by a progestin as a potential new contraceptive method. On menstrual cycle days 2, 9, 16, and 23 (onset of menses = Day 1) monkeys were divided into two groups: 1) those injected sc with 0.1 mg/kg Nal-Glu ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(09)91007-1

    authors: Danforth DR,Williams RF,Hsiu JG,Roh SI,Hahn D,McGuire JL,Hodgen GD

    更新日期:1990-06-01 00:00:00

  • The probability of side effects with ovral, norinyl 1/50 and norlestrin.

    abstract::This report provides specific information on the prevalence rates of the most common side effects during the first 3 cycles of use of 3 combination oral contraceptives (OCs) containing 50 mcg estrogen. The probabilities of a symptom occurring for the first time, or persisting once present, during the initial cycles of...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(79)90050-7

    authors: Berger GS,Edelman DA,Talwar PP

    更新日期:1979-11-01 00:00:00

  • Rebound of medication abortion in Texas following updated mifepristone label.

    abstract:BACKGROUND:In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label. METHODS:Using data collected directly from Texas abortion facilities, we evaluated changes in the provision and use of medication abortion durin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.01.001

    authors: Baum SE,White K,Hopkins K,Potter JE,Grossman D

    更新日期:2019-05-01 00:00:00

  • Determinants of contraceptive method choice after first delivery, before first abortion, and after first abortion in east China.

    abstract::A 10% sample of the data from East China from the two-per-thousand fertility and contraception survey of the Chinese State Family Planning Committee was analysed to study determinants of contraceptive choice in three situations: after first surviving delivery; before first abortion after first surviving delivery; and ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(93)90022-y

    authors: Gu J,Campbell MJ

    更新日期:1993-06-01 00:00:00

  • High speed cinematography of the initial break-point of latex condoms during the air burst test.

    abstract::High speed cinematography of latex condoms inflated to burst under standard (ISO) conditions reveals that rupture of the condom typically is initiated at a small focal point on the shank of the condom and then rapidly propagates throughout the condom's surface, often ending with partial or full severance of the condom...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(09)91004-6

    authors: Stube R,Voeller B,Davidhazy A

    更新日期:1990-06-01 00:00:00

  • Do retroverted uteri adversely affect insertions and performance of IUDs?

    abstract::A large international multi-center IUD data set (N = 5520) coordinated by Family Health International was analysed to determine if the uterine position of a woman (anteverted, mid-positioned or retroverted) affects the ease of IUD insertion and if knowledge of uterine position would diminish insertion-related problems...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(90)90059-5

    authors: Chi IC,Farr G,Dominik R,Robinson N

    更新日期:1990-05-01 00:00:00

  • Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.

    abstract:BACKGROUND:A formulation of depot medroxyprogesterone acetate (DMPA) has been developed that allows subcutaneous injection (104 mg/0.65 mL; DMPA-SC) and achieves highly effective contraception with a similar tolerability profile to intramuscular DMPA (150 mg/mL; DMPA-IM). STUDY DESIGN:This randomized, evaluator-blinde...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.contraception.2009.02.005

    authors: Kaunitz AM,Darney PD,Ross D,Wolter KD,Speroff L

    更新日期:2009-07-01 00:00:00